Agenus To Present At The JMP Securities Annual Healthcare Conference

LEXINGTON, Mass., July 2, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the JMP Securities 8 th Annual Healthcare Conference, which will be held at the St. Regis New York. Dr. Garo Armen, Chairman and CEO of Agenus, will present a corporate overview on Tuesday, July 9 th at 12:30 pm ET.

Web Cast Information                                                                         

The live and archived webcast of the company presentation will be accessible from the company's website at www.agenusbio.com/webcast . Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Agenus website for one month following the conference.

About Agenus

Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. For more information, please visit www.agenusbio.com .
CONTACT: Media and Investor Contact:         Jonae R. Barnes         Vice President         Investor Relations and         Corporate Communications         jonae.barnes@agenusbio.com         617-818-2985

company logo

If you liked this article you might like

Market's Trading Range Loosens Up

These 5 Stocks Under $10 Could Ignite Soon

These 5 Stocks Under $10 Could Explode Up Soon

Bullish and Bearish Reversals for the Week

4 Momentum Stocks You Should Watch Now